Example: tourism industry
Ceftriaxone – safety in neonates - WHO
term neonates with Gram negative bacterial meningitis treated with a third generation cephalosporin and amikacin [4]. In a study comparing cefotaxime and ceftriaxone for severe bacterial infections in children, 22 neonates were enrolled. Both were effective and adverse reactions were rare[5]. Other early studies also have shown it to be
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
ACNS Standardized EEG Terminology and Categorization for ...
www.acns.orgChildren's National Medical Center George Washington University School of Medicine Courtney J. Wusthoff, MD ... Critically ill neonates are at high risk for adverse neurologic sequelae but the bedside evaluation of a neonate’s neurologic status, especially cortical functioning, is
Recommended Antimicrobial Dosage Schedules for Neonates
www.healthcare.uiowa.eduNote: In neonates, lipid formulations of amphotericin have limited penetration into the central nervous system, kidneys, urinary tract, and eyes than conventional amphotericin and are not preferred in most cases Ampicillin 100mg/kg/dose IV ≤29 wks PMA: q12h (≤28d), q8h (>28d) 30-34 wks PMA: q12h(≤14d), q8h (>14d) ≥35 wks PMA: q8h
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govneonates: 5 mg/kg/24 hr or 150 mg/m 2/24 hr. Maximum daily dosage is 300 mg. Divide into four doses, admin-istered intravenously at a rate generally not exceed-ing 25 mg/min, or deep intramuscularly. Adults: 10 mg to 50 mg intravenously at a rate gener-ally not exceeding 25 mg/min, or deep intramuscu-larly, 100 mg if required; maximum daily ...
INTEGRATED MANAGEMENT OF PREGNANCY AND …
www.who.intneonates (1) (about 5% of all neonatal deaths (2002 data)) and up to 30 000 women (2) (about 5% of all maternal deaths) each year. If the mother is not immunized with the correct number of doses of tetanus toxoid vaccine, neither she nor her newborn infant is protected against tetanus at delivery. Tetanus is caused by a toxin produced during
Nipah Virus (NiV)
www.cdc.govNipah Virus (NiV) National Center for Emerging and Zoonotic Infectious Diseases Division of High-Consequence Pathogens and Pathology (DHCPP) Nipah virus (NiV) is a member of the family Paramyxoviridae, genus Henipavirus.NiV was initially isolated and identified in 1999